ENTX - Entera Bio Ltd - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ENTX is currently covered by 1 analysts with an average price target of $8.04. This is a potential upside of $6.05 (304.02%) from yesterday's end of day stock price of $1.99.

Entera Bio Ltd's activity chart (see below) currently has 8 price targets and 12 ratings on display. The stock rating distribution of ENTX is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for ENTX is $10, Lowest price target is $10, average price target is $10.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 18-Mar-2025. First documented stock forecast 12-Mar-2021.

Best performing analysts who are covering ENTX - Entera Bio Ltd:

Kalpit Patel Jason Mccarthy Raghuram Selvaraju Nathan Weinstein

Currently out of the existing stock ratings of ENTX, 7 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$10

$8.14 (437.63%)

3 months ago
(18-Mar-2025)

0/4 (0%)

$8.05 (412.82%)

Buy

$5

$3.14 (168.82%)

$6

2 years 10 months 30 days ago
(19-Jul-2022)

0/4 (0%)

$3.55 (244.83%)

Buy

$12

$10.19 (562.98%)

$12

3 years 2 months 27 days ago
(22-Mar-2022)

0/2 (0%)

$9.5 (380.00%)

Buy

$10

$9.17 (1104.82%)

4 years 3 months 6 days ago
(12-Mar-2021)

0/1 (0%)

$3.1 (44.93%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ENTX (Entera Bio Ltd) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ENTX (Entera Bio Ltd) with a proven track record?

KALPIT PATEL

Which analyst has the current lower performing score on ENTX (Entera Bio Ltd) with a proven track record?

NATHAN WEINSTEIN

Which analyst has the most public recommendations on ENTX (Entera Bio Ltd)?

Kalpit Patel works at B. RILEY and has 3 price targets and 2 ratings on ENTX

Which analyst is the currently most bullish on ENTX (Entera Bio Ltd)?

Nathan Weinstein with highest potential upside - $10.19

Which analyst is the currently most reserved on ENTX (Entera Bio Ltd)?

Kalpit Patel with lowest potential downside - $3.14

Entera Bio Ltd in the News

Entera Bio Announces First Quarter 2025 Financial Results and Business Updates

JERUSALEM, May 09, 2025 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key business updates for the quarter ended March 31, 2025. “During Q1 2025, Entera continued to generate intrinsic value with progress across our programs while significantly...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?